Evidence map›Paper›PMID 31925544›Full record

ArticleMetabolomics : Official journal of the Metabolomic Society2020

The differential activation of metabolic pathways in leukemic cells depending on their genotype and micro-environmental stress.

Caroline Lo Presti, Florence Fauvelle, Julie Mondet, Pascal Mossuz

Abstract read
PubMed Publisher
In one paragraph

Article in Metabolomics : Official journal of the Metabolomic Society, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Caroline Lo PrestiDepartment of Biological Hematology, Grenoble Alpes University Hospital, Grenoble, France. clopresti@chu-grenoble.fr.
Florence FauvelleUGA/INSERM U1216, Grenoble Institute of Neurosciences, Grenoble, France.
Julie MondetUGA/INSERM U1209/CNRS 5309, Institute for Advanced Biosciences, Grenoble, France.
Pascal MossuzDepartment of Biological Hematology, Grenoble Alpes University Hospital, Grenoble, France.
Université Grenoble Alpes · FRCentre National de la Recherche Scientifique · FRInserm · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionAcute myeloid leukemia (AML) is characterized by a set of malignant proliferations leading to an accumulation of blasts in the bone marrow and blood. The prognosis is pejorative due to the molecular complexity and pathways implicated in leukemogenesis.

objectivesOur research was focused on comparing the metabolic profiles of leukemic cells in basal culture and deprivation conditions to investigate their behaviors under metabolic stress.

methodsWe performed untargeted metabolomics using

resultsIn the basal state, each leukemic cell line exhibited a specific metabolic signature related to the diversity of AML subtypes represented and their phenotypes. When cultured in a serum-free medium, they showed quick metabolic adaptation and continued to proliferate and survive despite the lack of nutrients. Low apoptosis was observed. Increased phosphocholine and glutathione was a common feature of all the observed cell lines, with the maximum increase in these metabolites at 24 h of culture, suggesting the involvement of lipid metabolism and oxidative stress regulators in the survival mechanism developed by the leukemic cells.

conclusionsOur study provides new insights into the metabolic mechanisms in leukemogenesis and suggests a hierarchy of metabolic pathways activated within leukemic cells, some dependent on their genotypes and others conserved among the subtypes but commonly induced under micro-environmental stress.

Indexed as

GenotypeMetabolic Networks and PathwaysStress, PhysiologicalCell Line, TumorCulture Media, Serum-FreeHumansLeukemiaMetabolomeCulture Media, Serum-FreeAcute myeloid leukemiaHRMAS-NMRMetabolic pathwaysMetabolomics

Identifiers

PMID31925544
OpenAlexW2999433265

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.